[Perspectives in the treatment of arterial hypertension: interventions at the dopaminergic system level].
Soares-da-Silva
P
P
D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism*; D015259:Dopamine Agents / Q000627:therapeutic use*; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D007668:Kidney / Q000378:metabolism* / Q000503:physiopathology; D011954:Receptors, Dopamine / Q000378:metabolism
D015259:Dopamine Agents; D011954:Receptors, Dopamine; C017342:gamma-glutamyl DOPA; D004295:Dihydroxyphenylalanine; D004299:Dopamine beta-Hydroxylase; D004298:Dopamine
Perspectivas na terapêutica da hipertensão arterial: intervenções a nível do sistema dopaminérgico.